rs144668507
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_152783.5(D2HGDH):c.1066C>T(p.His356Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00308 in 1,613,946 control chromosomes in the GnomAD database, including 129 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_152783.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
D2HGDH | NM_152783.5 | c.1066C>T | p.His356Tyr | missense_variant | 8/10 | ENST00000321264.9 | NP_689996.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
D2HGDH | ENST00000321264.9 | c.1066C>T | p.His356Tyr | missense_variant | 8/10 | 1 | NM_152783.5 | ENSP00000315351 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0166 AC: 2530AN: 152208Hom.: 71 Cov.: 33
GnomAD3 exomes AF: 0.00409 AC: 1028AN: 251188Hom.: 23 AF XY: 0.00289 AC XY: 393AN XY: 135864
GnomAD4 exome AF: 0.00166 AC: 2424AN: 1461620Hom.: 57 Cov.: 33 AF XY: 0.00136 AC XY: 990AN XY: 727112
GnomAD4 genome AF: 0.0167 AC: 2539AN: 152326Hom.: 72 Cov.: 33 AF XY: 0.0155 AC XY: 1155AN XY: 74488
ClinVar
Submissions by phenotype
D-2-hydroxyglutaric aciduria 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 04, 2017 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 31, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at